Social media

A recent peer-reviewed study co-authored by Tim Clark, VP Clinical Sciences at ICON, reviewed UK HRA submissions to evaluate how estimands are being defined post-ICH E9(R1). Findings show that while usage has increased,...

A recent peer-reviewed study co-authored by Dr. Tim Clark, VP Clinical Sciences at ICON, reviewed UK HRA submissions to evaluate how estimands are being defined post-ICH E9(R1). Findings show that while usage has increa...

Integrating modern technologies and scientific advances into cardiovascular outcomes trials can streamline their execution and improve efficiency. Find an overview of tools and strategic approaches sponsors can use to ma...

Integrating modern technologies and scientific advances into cardiovascular outcomes trials can streamline their execution and improve efficiency. Find an overview of tools and strategic approaches sponsors can use to ma...

In this latest thought leadership article on biosimilar drug development, the head of ICON’s Centre for Biosimilar Drug Development outlines what the next era of biosimilars will look like. As the patent cliff approach...

In this latest thought leadership article on biosimilar drug development, the head of ICON’s Centre for Biosimilar Drug Development outlines what the next era of biosimilars will look like. As the patent cliff approach...

Our Talent Acquisition team recently took part in the University of Buenos Aires Career Fair at the Faculty of Pharmacy and Biochemistry. It was a great opportunity to connect with students and future professionals, shar...

Accelerating enrollment through smarter access. Explore how ICON’s extensive patient access network and tailored recruitment strategies helped a sponsor meet enrollment goals faster and more efficiently. https://ow.ly/1n...

Accelerating enrollment through smarter access. Explore how ICON’s extensive patient access network and tailored recruitment strategies helped a sponsor meet enrollment goals faster and more efficiently. https://ow.ly/wV...

Visit the ICON team at #ACR25, booth 1501 to discover how our strategic solutions and innovative methods help reduce patient burden, meet enrolment targets, and accelerate access to new treatment options for autoimmune d...

Systemic autoimmune rheumatic diseases are rising globally. Speak with ICON experts at #ACR25, booth \#1501 to learn how our deep experience delivering rheumatology studies helps sponsors to advance autoimmune therapie...

Obesity trials are evolving, and weight alone is no longer enough. Join our live webinar to explore how the complementary tools of COAs + DHTs can deliver richer patient insights, enhancing obesity clinical trials. 📅 Oc...